Myers Timothy R
Asthma Center, Cleveland, OH 44106, USA.
Respir Care. 2006 Jun;51(6):619-31.
For over 70 years, helium-oxygen mixture (heliox) has been promoted as adjunctive therapy to overcome airflow-obstructive disorders and lesions. In the past 2 decades heliox has gained widespread support in many pediatric emergency departments and intensive care units, in treatment of infants and children with both upper and lower airway obstruction. Because heliox is less dense than air or oxygen, it provides more laminar flow in obstructed airways, and it is purported to reduce work of breathing, respiratory distress, and postextubation stridor. Clinical evidence of the effectiveness of heliox in pediatric patients with airflow obstruction is relatively sparse and appears in the literature primarily as case presentations, case series, and small, uncontrolled studies. This article reviews the rationale and methods for heliox treatment of children with asthma, airway obstruction, bronchiolitis, and croup.
七十多年来,氦氧混合气(氦氧)一直被推广为克服气流阻塞性疾病和病变的辅助治疗方法。在过去二十年中,氦氧在许多儿科急诊科和重症监护病房获得了广泛支持,用于治疗患有上、下呼吸道阻塞的婴幼儿。由于氦氧的密度低于空气或氧气,它在阻塞气道中提供更层流的气流,据称可减少呼吸功、呼吸窘迫和拔管后喘鸣。氦氧在患有气流阻塞的儿科患者中有效性的临床证据相对较少,主要以病例报告、病例系列和小型非对照研究的形式出现在文献中。本文综述了氦氧治疗儿童哮喘、气道阻塞、细支气管炎和喉炎的理论依据和方法。